Smith & Nephew bets on technology that ‘sees through the skin’

The Telegraph have published an article announcing the £2.5 million investment by Smith & Nephew to be used to expand the Michelson Diagnostics’ commercial presence in Germany; launch the Company’s next generation VivoSight OCT tissue-imaging system; complete the ongoing US multi-centre clinical biopsy avoidance study and explore further applications of the VivoSight system in areas such as wound care and dentistry.

View the full article here